ES8604861A1 - Procedimiento para la preparacion de derivados de fenilace- tonitrilo - Google Patents

Procedimiento para la preparacion de derivados de fenilace- tonitrilo

Info

Publication number
ES8604861A1
ES8604861A1 ES546908A ES546908A ES8604861A1 ES 8604861 A1 ES8604861 A1 ES 8604861A1 ES 546908 A ES546908 A ES 546908A ES 546908 A ES546908 A ES 546908A ES 8604861 A1 ES8604861 A1 ES 8604861A1
Authority
ES
Spain
Prior art keywords
radical
alkyl
branched
linear chain
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES546908A
Other languages
English (en)
Spanish (es)
Other versions
ES546908A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of ES8604861A1 publication Critical patent/ES8604861A1/es
Publication of ES546908A0 publication Critical patent/ES546908A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
ES546908A 1984-09-12 1985-09-12 Procedimiento para la preparacion de derivados de fenilace- tonitrilo Expired ES8604861A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843433383 DE3433383A1 (de) 1984-09-12 1984-09-12 Neue phenyl-acetonitril-derivate

Publications (2)

Publication Number Publication Date
ES8604861A1 true ES8604861A1 (es) 1986-03-16
ES546908A0 ES546908A0 (es) 1986-03-16

Family

ID=6245162

Family Applications (1)

Application Number Title Priority Date Filing Date
ES546908A Expired ES8604861A1 (es) 1984-09-12 1985-09-12 Procedimiento para la preparacion de derivados de fenilace- tonitrilo

Country Status (16)

Country Link
US (1) US4612313A (en, 2012)
EP (1) EP0175249A3 (en, 2012)
JP (1) JPS6185355A (en, 2012)
AU (1) AU562730B2 (en, 2012)
CA (1) CA1248533A (en, 2012)
CS (1) CS255894B2 (en, 2012)
DD (1) DD237504A5 (en, 2012)
DE (1) DE3433383A1 (en, 2012)
DK (1) DK413685A (en, 2012)
ES (1) ES8604861A1 (en, 2012)
FI (1) FI853343A7 (en, 2012)
GR (1) GR852167B (en, 2012)
HU (1) HU195644B (en, 2012)
IL (1) IL76327A (en, 2012)
SU (1) SU1508956A3 (en, 2012)
ZA (1) ZA856942B (en, 2012)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4612329A (en) * 1984-10-17 1986-09-16 Hokuriku Pharmaceutical Co., Ltd. Pharmaceutical alpha-aminoalkyl-alpha-alkylphenylacetonitriles
DE3642331A1 (de) * 1986-12-11 1988-06-23 Basf Ag Basisch substituierte phenylacetonitrile, ihre herstellung und diese enthaltende arzneimittel
GB8717068D0 (en) * 1987-07-20 1987-08-26 Fujisawa Pharmaceutical Co Nitric ester derivative
NL9001955A (nl) * 1990-09-05 1992-04-01 Cedona Pharm Bv Nieuwe thiazolidinederivaten.
US6263940B1 (en) 1999-04-21 2001-07-24 Axon Corporation In-line continuous feed sleeve labeling machine and method
TW200821303A (en) * 2006-08-08 2008-05-16 Speedel Experimenta Ag Organic compounds
CN101754678B (zh) 2007-06-20 2014-04-16 里程医药有限公司 短效苯烷基胺钙通道阻断剂及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1154810B (de) 1961-04-01 1963-09-26 Knoll Ag Verfahren zur Herstellung basisch substituierter Phenylacetonitrile
US4340603A (en) * 1980-08-13 1982-07-20 Interx Research Corporation Novel inotropic prodrugs
DE3144150A1 (de) * 1981-04-10 1982-12-09 Basf Ag, 6700 Ludwigshafen (omega)-cyan-1,(omega)-diphenyl-azaalkan-derivate, ihre herstellung und diese enthaltende arzneimittel

Also Published As

Publication number Publication date
FI853343L (fi) 1986-03-13
IL76327A (en) 1989-06-30
CS255894B2 (en) 1988-03-15
DK413685A (da) 1986-03-13
FI853343A7 (fi) 1986-03-13
DK413685D0 (da) 1985-09-11
IL76327A0 (en) 1986-01-31
ES546908A0 (es) 1986-03-16
HU195644B (en) 1988-06-28
HUT38302A (en) 1986-05-28
CS652285A2 (en) 1987-07-16
DE3433383A1 (de) 1986-03-20
GR852167B (en, 2012) 1986-01-03
ZA856942B (en) 1986-05-28
AU4709985A (en) 1986-03-20
SU1508956A3 (ru) 1989-09-15
EP0175249A2 (de) 1986-03-26
US4612313A (en) 1986-09-16
CA1248533A (en) 1989-01-10
DD237504A5 (de) 1986-07-16
EP0175249A3 (de) 1987-08-19
JPS6185355A (ja) 1986-04-30
AU562730B2 (en) 1987-06-18
FI853343A0 (fi) 1985-08-30

Similar Documents

Publication Publication Date Title
ES8704473A1 (es) Procedimiento para la produccion de derivados de la 13-beta-milbemicina
ES480109A1 (es) Procedimkiento para la preparacion de derivados de imidazo- lidina.
ES8605511A1 (es) Un procedimiento para la preparacion de derivados de tiazol,2, 4, disustituidos.
ES8701138A1 (es) Un procedimiento para la preparacion de derivados de glicerina.
ES8801222A1 (es) Un procedimiento para la preparacion de nuevos derivados de ciclopenta(d)pirimidina
ES8106302A1 (es) Un procedimiento para la preparacion de derivados de acido trans-(4-oxo-4h-quinazolin-3-il)-2-propenoico
ES8604861A1 (es) Procedimiento para la preparacion de derivados de fenilace- tonitrilo
ES8801285A1 (es) Procedimiento para la obtencion de derivados de la 13-beta-milbemicina
ES8303287A1 (es) Un procedimiento para preparar compuestos de aminoetanol.
ES8304070A1 (es) "procedimiento para la preparacion de nuevas amidas de acidos carboxilicos".
ES8608502A1 (es) Procedimiento para la obtencion de benzofuranonas
ES8307718A1 (es) "procedimiento de preparar amidoaminoacidos y similares".
ES8305345A1 (es) "procedimiento para la preparacion de nuevos derivados de acidos 2-amino-carboxilicos".
ES8301878A1 (es) Procedimiento para la preparacion de derivados de ciclohexe-no
ES8607960A1 (es) Procedimiento para preparar acidos aroil-benzofuran y benzo-tiofen-aceticos y-propionicos
ES2032582T3 (es) Procedimiento para preparar derivados de la oxima del 1,2,5,6,-tetrahidropiridin -3-carboxialdehido.
ES8105692A1 (es) Un procedimiento para preparar acidos 2-nitrobenzoicos sus- tituidos con fenoxi en la posicion 5
ES2010736A6 (es) Procedimiento para preparar nuevos derivados del acido furanuronico.
ES8403461A1 (es) Procedimiento de preparacion de derivados de imidazolidina.
ES8405391A1 (es) Un procedimiento para la preparacion de un derivado de tetrahidro-1h-piridoindol.
ES8503676A1 (es) Procedimiento de producir derivados de acido oxazolacetico
ES8204410A1 (es) Procedimiento de obtencion de derivados de acido fenilaceti-co
ES8402310A1 (es) Un procedimiento para la preparacion de agentes antibacterianos unidos de dicarboxilato de 1,1-alcanodiol.
ES8707963A1 (es) Un procedimiento para preparar derivados de penem
ES8304557A1 (es) Un procedimiento para la preparacion de derivados de ciclo- hepteno.